We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
Cap. Flow
-$592M
Cap. Flow %
-18.42%
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88

Top Buys

Rank Stock Value
1
ATAI icon
AtaiBeckley Inc
ATAI
+$25.3M
2
AGL icon
Agilon Health
AGL
+$13.5M
3
LLY icon
Eli Lilly
LLY
+$13.2M
4
PRVA icon
Privia Health
PRVA
+$12.8M
5
LNTH icon
Lantheus
LNTH
+$12.3M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$23.9M
2
VCEL icon
Vericel Corp
VCEL
+$20.8M
3
ALGN icon
Align Technology
ALGN
+$19M
4
SIBN icon
SI-BONE Inc
SIBN
+$17.5M
5
STAA icon
STAAR Surgical
STAA
+$14.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.64%
2 Industrials 1.41%
3 Materials 0.54%
4 Financials 0.48%
5 Consumer Staples 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUNG icon
26
Pulmonx
LUNG
$100M
$26.3M 0.82%
595,231
+152,335
+34% +$6.63M
DHR icon
27
PUT
Danaher
DHR
$146B
$24.7M 0.77%
+103,889
New +$23M
NTRA icon
28
Natera
NTRA
$45.4B
$24.6M 0.77%
216,816
-30,828
-12% -$3.15M
ATAI icon
29
AtaiBeckley Inc
ATAI
$2.68B
$23.2M 0.72%
+1,371,824
New +$25.3M
ABT icon
30
CALL
Abbott
ABT
$190B
$23.2M 0.72%
+200,000
New +$23.3M
HYFM icon
31
Hydrofarm Holdings
HYFM
$7.96M
$22.9M 0.71%
38,777
-6,055
-14% -$3.56M
TMO icon
32
PUT
Thermo Fisher Scientific
TMO
$224B
$22.7M 0.71%
45,000
+25,000
+125% +$11.8M
RCM
33
DELISTED
R1 RCM Inc. Common Stock
RCM
$21.3M 0.66%
959,522
+13,035
+1% +$315K
ORGO icon
34
Organogenesis Holdings
ORGO
$243M
$21.3M 0.66%
1,281,600
-225,952
-15% -$4.21M
RVTY icon
35
PUT
Revvity
RVTY
$12.9B
$19.7M 0.61%
127,500
+62,500
+96% +$8.78M
APR
36
DELISTED
Apria, Inc. Common Stock
APR
$19.6M 0.61%
699,720
-66,992
-9% -$1.97M
LIVN icon
37
LivaNova
LIVN
$4.34B
$19.4M 0.6%
230,413
-21,989
-9% -$1.81M
OM icon
38
Outset Medical
OM
$91M
$18.6M 0.58%
24,849
+565
+2% +$432K
QTRX icon
39
Quanterix
QTRX
$123M
$18M 0.56%
306,467
+65,139
+27% +$3.78M
AMRS
40
DELISTED
Amyris Inc.
AMRS
$17.5M 0.54%
1,069,137
+224,115
+27% +$3.34M
MDVL
41
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$16.7M 0.52%
27,248
-19,596
-42% -$12.8M
PACB icon
42
Pacific Biosciences
PACB
$354M
$16.5M 0.51%
471,777
-115,178
-20% -$3.35M
QTNT
43
DELISTED
Quotient Limited Ordinary Shares
QTNT
$16.3M 0.51%
111,643
+57,233
+105% +$9.15M
IRTC icon
44
CALL
iRhythm Holdings
IRTC
$4.03B
$15.6M 0.49%
+235,600
New +$18.7M
AGL icon
45
Agilon Health
AGL
$1.46B
$15.6M 0.48%
+15,358
New +$13.5M
PRVA icon
46
Privia Health
PRVA
$2.79B
$15.4M 0.48%
+346,044
New +$12.8M
LLY icon
47
Eli Lilly
LLY
$1.08T
$15.1M 0.47%
+65,922
New +$13.2M
LNTH icon
48
Lantheus
LNTH
$6.57B
$14.8M 0.46%
+536,872
New +$12.3M
MDXG icon
49
MiMedx Group
MDXG
$627M
$14.6M 0.46%
1,170,300
+33,349
+3% +$361K
UHS icon
50
PUT
Universal Health Services
UHS
$9.97B
$14.4M 0.45%
+98,200
New +$14.8M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.

  • Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
  • Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
  • Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
  • Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
  • Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.